Schroeder Mark S, EVP, President of Diagnostics and COO at Labcorp Holdings Inc. ($LH), made one open market sale of common shares in the last 365 days, totaling about $610 thousand. His most recent LH insider sale occurred on March 28, 2025. This ranks him 6,035th out of 11,678 insiders by sales value, well below the average of $8.6 million per 6.4 transactions. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Common Stock | 2968 | $0.00 | 14,145.1426 | 83,000,000 | 26.55% | 0.00% |
| March 26, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Common Stock | 9304 | $0.00 | 15,777.1426 | 83,000,000 | 143.73% | 0.01% |
| March 26, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 4600 | $268.38 | 11,177.1426 | 83,000,000 | 29.16% | 0.01% |
| March 26, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 1468 | $268.38 | 12,677.1426 | 83,000,000 | 10.38% | 0.00% |
| Feb. 11, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 259 | $289.89 | 6,473.1426 | 83,000,000 | 3.85% | 0.00% |
| Feb. 11, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 806 | $0.00 | 6,732.1426 | 83,000,000 | 13.60% | 0.00% |
| Feb. 11, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 806 | $0.00 | 2,358.0000 | 83,000,000 | 25.47% | 0.00% |
| Feb. 9, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 53 | $274.01 | 5,926.1426 | 83,000,000 | 0.89% | 0.00% |
| Feb. 7, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 164 | $0.00 | 6,145.1426 | 83,000,000 | 2.74% | 0.00% |
| Feb. 7, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 517 | $0.00 | 5,981.1426 | 83,000,000 | 9.46% | 0.00% |
| Feb. 6, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 239 | $277.20 | 5,464.1426 | 83,000,000 | 4.19% | 0.00% |
| Feb. 6, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 743 | $0.00 | 5,703.1426 | 83,000,000 | 14.98% | 0.00% |
| Feb. 7, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 164 | $0.00 | 3,164.0000 | 83,000,000 | 4.93% | 0.00% |
| Feb. 7, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 517 | $0.00 | 3,328.0000 | 83,000,000 | 13.45% | 0.00% |
| Feb. 6, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 743 | $0.00 | 3,845.0000 | 83,000,000 | 16.19% | 0.00% |
| Feb. 9, 2026 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 166 | $274.01 | 5,979.1426 | 83,000,000 | 2.70% | 0.00% |
| March 27, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 2205 | $231.67 | 7,595.1426 | 83,400,000 | 22.50% | 0.00% |
| March 28, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | S | Common Stock | 2635 | $231.67 | 4,960.1426 | 83,400,000 | 34.69% | 0.00% |
| March 27, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Common Stock | 4840 | $0.00 | 9,800.1426 | 83,400,000 | 97.58% | 0.01% |
| Feb. 28, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Non-qualified Stock Options | 3903 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 28, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | S | Common Stock | 5339 | $249.23 | 4,960.1426 | 83,400,000 | 51.84% | 0.01% |
| Feb. 28, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 3903 | $131.43 | 10,299.1426 | 83,400,000 | 61.02% | 0.00% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 134 | $245.14 | 6,396.1426 | 83,400,000 | 2.05% | 0.00% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 473 | $0.00 | 6,530.1426 | 83,400,000 | 7.81% | 0.00% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Non-qualified Stock Options | 7300 | $0.00 | 7,300.0000 | 83,400,000 | 9999.99% | 0.01% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Restricted Stock Unit | 2420 | $0.00 | 5,061.0000 | 83,400,000 | 91.63% | 0.00% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 473 | $0.00 | 4,588.0000 | 83,400,000 | 9.35% | 0.00% |
| Feb. 7, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 164 | $0.00 | 2,641.0000 | 83,400,000 | 5.85% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 743 | $0.00 | 5,779.1426 | 83,400,000 | 14.75% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 210 | $247.74 | 5,569.1426 | 83,400,000 | 3.63% | 0.00% |
| Feb. 7, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 517 | $0.00 | 6,086.1426 | 83,400,000 | 9.28% | 0.00% |
| Feb. 7, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 146 | $246.27 | 5,940.1426 | 83,400,000 | 2.40% | 0.00% |
| Feb. 7, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 164 | $0.00 | 6,104.1426 | 83,400,000 | 2.76% | 0.00% |
| Feb. 7, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 47 | $246.27 | 6,057.1426 | 83,400,000 | 0.77% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 743 | $0.00 | 3,322.0000 | 83,400,000 | 18.28% | 0.00% |
| Feb. 7, 2025 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 517 | $0.00 | 2,805.0000 | 83,400,000 | 15.56% | 0.00% |
| April 1, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | S | Common Stock | 6477 | $217.29 | 5,036.1426 | 83,900,000 | 56.26% | 0.01% |
| March 27, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 5079 | $216.57 | 11,513.1426 | 83,900,000 | 30.61% | 0.01% |
| March 27, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 11556 | $0.00 | 16,592.1426 | 83,900,000 | 229.46% | 0.01% |
| March 27, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 11556 | $0.00 | 4,065.0000 | 83,900,000 | 73.98% | 0.01% |
| March 7, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | S | Common Stock | 5048 | $218.45 | 5,036.1426 | 83,900,000 | 50.06% | 0.01% |
| March 7, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Non-qualified Stock Options | 2119 | $0.00 | 0.0000 | 83,900,000 | 100.00% | 0.00% |
| March 7, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 2119 | $117.09 | 10,084.1426 | 83,900,000 | 26.60% | 0.00% |
| Feb. 12, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 126 | $227.45 | 7,965.1426 | 83,900,000 | 1.56% | 0.00% |
| Feb. 11, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 472 | $0.00 | 15,621.0000 | 83,900,000 | 2.93% | 0.00% |
| Feb. 11, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 472 | $0.00 | 8,091.1426 | 83,900,000 | 6.19% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 517 | $0.00 | 7,638.1426 | 83,900,000 | 7.26% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 163 | $0.00 | 16,093.0000 | 83,900,000 | 1.00% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 517 | $0.00 | 16,256.0000 | 83,900,000 | 3.08% | 0.00% |
| Feb. 6, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Non-qualified Stock Options | 6900 | $0.00 | 6,900.0000 | 83,900,000 | 9999.99% | 0.01% |
| Feb. 6, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Restricted Stock Unit | 2230 | $0.00 | 16,773.0000 | 83,900,000 | 15.33% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 44 | $223.71 | 7,619.1426 | 83,900,000 | 0.57% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 163 | $0.00 | 7,663.1426 | 83,900,000 | 2.17% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 138 | $223.71 | 7,500.1426 | 83,900,000 | 1.81% | 0.00% |
| Feb. 2, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 132 | $221.54 | 7,121.1426 | 83,900,000 | 1.82% | 0.00% |
| Feb. 2, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 495 | $0.00 | 14,543.0000 | 83,900,000 | 3.29% | 0.00% |
| Feb. 2, 2024 | LABCORP HOLDINGS INC. | $LH | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 495 | $0.00 | 7,253.1426 | 83,900,000 | 7.32% | 0.00% |